Submitting Continuous Glucose Monitoring Data in Clinical Trials
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 6, 2026
May 7, 2026
242cfeef-dde5-46f4-b50e-9669a5a75ca9
Related Documents
Submitting Clinical Trial Datasets and Documentation for Clinical Outcome Assessments Using Item Response Theory
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Submitting Nonclinical Datasets for Evaluation of Rodent Carcinogenicity Studies of Pharmaceuticals
Guidance DocumentMay 1, 2021Center for Drug Evaluation and Research
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox